Hosted by Dailymotion. For legal issues report at the Copyright Center, report us on DMC, or use the Instant Removal tool.
Kotak Institutional Equities upbeat on Cipla
Description
Currently, they prefer Cipla and Torrent pharma which have a strong domestic franchise underpinning the valuation and providing downside support. Cipla remains their top pick, said Chirag Talati, Associate Director, Kotak Institutional Equities
More from User
03:06
Auto Expo 2020: Here's a look at MG Motor India's future ready portfolio
CNBC-TV18
02:30
Here’s what restauranteurs make of Mumbai 24x7
CNBC-TV18
04:15
Omar Abdullah's sister moves Supreme Court challenging his detention under the Public Safety Act
CNBC-TV18
04:02
Totally false that ousted CEO Neumann left with $1 Bn, says WeWork's executive chairman Marcelo Claure
CNBC-TV18
02:44
Indian ride hailing app Ola has rolled out its service in London
CNBC-TV18
02:35
London High Court to hear Mallya extradition case from tomorrow
CNBC-TV18
Related Videos
02:52
If I were FM | Associate Director, Kotak Institutional Equities
Mint
12:26
Sanjeev Prasad Of Kotak Institutional Equities On Indian Markets & More
ET NOW
05:17
Hitesh Goel of Kotak Institutional Equities on auto sector
CNBC-TV18
09:42
ET Now Exclusive: Sandeep Bhatia, Executive Director & Head of Sales, Kotak Institutional Equities
ET NOW
11:10
Sanjeev Prasad of Kotak Institutional Equities on market & specific sectors
CNBC-TV18
00:40
TLTROs To Work Once Credit Growth Picks Up: Kotak Institutional Equities' Rakshit
NDTV Profit